In brain tumors, this is observed in GBMs ([80,88,91], present article) and medulloblastomas [115,118], although specifically in SHH and Group 3 tumors, shorter patient survival may be related to lower NRP1 transcript levels [120]. The gene discussed is NRP1; the disease is medulloblastoma.